| Year |
Citation |
Score |
| 2014 |
Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, Harter DH, Goldberg JD, Hochman T, Merkelson A, Bloom MC, Sievert AJ, Resnick AC, Dhall G, Jones DT, et al. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro-Oncology. 16: 1408-16. PMID 24803676 DOI: 10.1093/Neuonc/Nou059 |
0.437 |
|
| 2013 |
Sievert AJ, Lang SS, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC. Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proceedings of the National Academy of Sciences of the United States of America. 110: 5957-62. PMID 23533272 DOI: 10.1073/Pnas.1219232110 |
0.501 |
|
| 2012 |
Stephen JH, Sievert AJ, Madsen PJ, Judkins AR, Resnick AC, Storm PB, Rushing EJ, Santi M. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases. Journal of Neurosurgery. Pediatrics. 9: 646-53. PMID 22656257 DOI: 10.3171/2012.2.Peds11285 |
0.461 |
|
| 2012 |
Lang S, Sievert AJ, Boucher KL, Madsen PJ, Slaunwhite E, Brewington D, Storm PB, Resnick AC. 193 Development of Pediatric Glioma Models for BRAF-targeted Therapy Neurosurgery. 71: E575. DOI: 10.1227/01.neu.0000417783.83750.a5 |
0.412 |
|
| 2012 |
Sievert AJ, Lang S, Storm PB, Resnick AC. Abstract B17: Mechanisms of resistance of BRAF fusions to first generation selective BRAF inhibitors Clinical Cancer Research. 18: B17-B17. DOI: 10.1158/1078-0432.MECHRES-B17 |
0.394 |
|
| 2012 |
Brognaro E, Ghods A, Feinstein D, Glick R, Connolly KJ, Meetze K, Boudrow A, Gyuris J, Han M, Hingtgen S, Figueiredo J, Farrar C, Farrar C, Deubgen M, Martinez-Quintanilla J, ... ... Sievert AJ, et al. LAB-TUMOR MODELS (IN VIVO/IN VITRO) Neuro-Oncology. 14: vi160-vi164. DOI: 10.1093/Neuonc/Nos241 |
0.428 |
|
| 2010 |
Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, Storm PB, Biegel JA. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro-Oncology. 12: 621-30. PMID 20156809 DOI: 10.1093/Neuonc/Noq007 |
0.494 |
|
| 2009 |
Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. Journal of Child Neurology. 24: 1397-408. PMID 19841428 DOI: 10.1177/0883073809342005 |
0.304 |
|
| 2009 |
Sievert AJ, Jackson EM, Gai X, Hakonarson H, Judkins AR, Resnick AC, Sutton LN, Storm PB, Shaikh TH, Biegel JA. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathology (Zurich, Switzerland). 19: 449-58. PMID 19016743 DOI: 10.1111/J.1750-3639.2008.00225.X |
0.502 |
|
| 2009 |
Sievert AJ, Jackson EM, Gai X, Hakonarson H, Judkins AR, Resnick AC, Sutton LN, Storm PB, Shaikh TH, Biegel JA. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene (Brain Pathol (2008) 19 (449-458)) Brain Pathology. 19: 550. DOI: 10.1111/J.1750-3639.2009.00298.X |
0.426 |
|
| Show low-probability matches. |